
Ambience Healthcare
B2B enterprise SaaS; per-provider annual contracts (per clinical FTE), land-and-expand into health systems, tiered by module suite
The Series B ($70M, Feb 2024, co-led by Kleiner Perkins & OpenAI Startup Fund) post-money valuation was not publicly disclosed, so no point is plotted for it. The only firmly disclosed round valuation is the Jul-2025 Series C at ~$1.25B; the 2022 Series A mark is a PitchBook estimate and Sacra's ~$1B is a secondary-market estimate of the same Series C round.
Earnings, margins, COGS & capex
Revenue is per-provider annual SaaS, sold into large academic and enterprise health systems via a land-and-expand motion (start in high-burnout specialties, expand system-wide). ARR reportedly roughly tripled across 2024 and reached ~$30M by mid-2025 on marquee logos (Cleveland Clinic, UCSF, Memorial Hermann). No audited financials, margins, or profitability disclosed - the company is a growth-stage private burning to capture share of the ambient-AI documentation land grab.
Income statement — where each revenue dollar goes
% of revenueOf every $1 of revenue, ~40¢ is cost of goods and ~60¢ operating expense, leaving ~0¢ of operating profit.
Revenue trend
Margins
LLM inference COGS is the key swing factor vs. traditional SaaS
presumed negative; scaling enterprise sales + R&D
presumed negative; funded by Series C
COGS structure
Not disclosed. Structurally, primary COGS is foundation-model inference (Ambience builds on OpenAI models and its own fine-tuned coding model trained with OpenAI reinforcement fine-tuning) plus cloud hosting and clinical/QA overhead. Inference cost per encounter is the central gross-margin lever and a differentiator vs. lower-touch scribe tools.
Capex
Not disclosed. Asset-light - no material physical capex; spend concentrates in R&D headcount and variable cloud/model compute (opex).
Latest earnings
n/a
No public guidance. Company frames 2026 as 'the year of maturity' - consolidation from pilots to proven, deployed infrastructure
- ARR (est., May 2025)
- ~$30M
- Last round valuation
- ~$1.25B (Jul 2025; Sacra ~$1B)
- Series C raised
- $243M
- Est. ambient-scribe market share
- ~13% (Becker's/KLAS, Oct 2025)
- Claimed provider utilization
- 70-80% (company-claimed; vs 30-40% cited for peers)
Growth drivers
- Land-and-expand within large IDNs — exclusive Cleveland Clinic deal (300+ clinicians, 20 specialties) and enterprise accounts at UCSF, Memorial Hermann, John Muir, GI Alliance, The Oncology Institute
- Module expansion beyond AutoScribe into AutoCDI, coding, AutoAVS, AutoRefer and prior-auth - raises ARPU from ~$2,800-3,200 to $4,000-5,000+ per provider
- Move up the value chain into revenue-cycle / revenue-integrity automation (coding, CDI, prior auth) - a far larger TAM than documentation
- Epic partnership / Toolbox program (2026) — distribution into Epic's ambient-voice ecosystem (Ambient Module, Haiku), broadening reach across Epic's install base
- Apr-2026 multiyear roadmap across five domains (clinical workflows, revenue integrity, patient engagement, care orchestration, research) plus performance-incentive contracts tied to financial outcomes, positioning as system-of-record infrastructure, not a point tool
Bull & bear
Ambience is the enterprise-grade, full-stack play on ambient clinical AI - not just a scribe but the documentation-to-revenue-integrity layer for large health systems, with the reference logos, utilization, and capital to compound into a category platform.
- Ambient AI is the clearest product-market fit for AI in healthcare; ~$1B of capital flowed into the category in 2025 and Ambience is a top-4 player with elite academic logos
- Land-and-expand + module attach (coding, CDI, prior-auth) drives ARPU and net-retention well above a single-product scribe - the path from ~$30M to $100M+ ARR is credible
- Moving into revenue-cycle automation attacks a TAM an order of magnitude larger than documentation, with a hard-dollar labor-savings ROI hospitals fund readily
- Autonomous coding at claimed better-than-human accuracy (OpenAI RFT model) plus outcome-linked contracts is a genuine wedge that legacy scribe tools lack
- Epic partnership + Cleveland Clinic-caliber references de-risk the enterprise sales cycle that gates the whole category
A sub-scale #3/#4 in a market where the two leaders have EHR/cloud distribution and bigger balance sheets, carried at a ~40x ARR mark that assumes it wins a commoditizing category with unproven margins.
- Microsoft/Nuance and Abridge together hold ~60%+ share and out-distribute/out-fund Ambience; ambient scribing is becoming commoditized table-stakes
- ~$1.25B valuation on ~$30M estimated ARR (~40x) leaves no room for a growth stumble or margin disappointment
- Gross margins are undisclosed and structurally exposed to LLM inference cost - the category may prove lower-margin than classic SaaS
- Epic and other EHRs can build native ambient documentation and relegate third-party tools to a thin integration layer
- Auto-coding introduces clinical-accuracy, compliance and reimbursement-fraud liability that could slow enterprise adoption or invite regulation
- Reliant on continued private financing; a funding-market cool-down would pressure a high-burn, unprofitable model
What it is worth
Private last-round mark + ARR-multiple sanity check vs. named peers (no public price / DCF possible).
<$0.75B
margin disappointment, EHR-native commoditization, or a funding-market cool-down forces a flat-to-down round.
~$1.25B
holds the Series C mark; grows into the multiple as ARR compounds but faces margin/share scrutiny.
$2.5B+
if module attach and RCM expansion drive ARR to $100M+ at healthy margins, an up-round re-rates it toward Abridge-tier multiples.
Last priced at ~$1.25B in the Jul 2025 Series C on an estimated ~$30M ARR (~40x ARR); Sacra pegs the same round nearer ~$1B. That multiple sits below Abridge's richer mark but well above mature health-IT SaaS (~6-12x), pricing Ambience for durable 50%+ growth and successful expansion into the larger RCM TAM. Reasonableness hinges on undisclosed gross margins holding under inference costs and on defending ~13% share against better-distributed leaders.
SWOT
Strengths
- Marquee enterprise logos and an exclusive Cleveland Clinic contract - strong reference base in academic medicine
- Breadth beyond scribing — coding, CDI, prior-auth and revenue-integrity modules create a wider wedge and higher ARPU than pure-scribe rivals
- High claimed clinician utilization (70-80%), the metric that determines net retention and system-wide expansion
- Deep-pocketed cap table (a16z, Oak HC/FT, OpenAI Startup Fund, Kleiner Perkins, Optum Ventures) and $243M of fresh capital
- Epic partnership / Toolbox integration lowers deployment friction inside the dominant EHR
Weaknesses
- Sub-scale vs. the leaders - ~13% share behind Microsoft/Nuance (~33%) and Abridge (~30%)
- ~$30M ARR against a ~$1.25B valuation implies a ~40x ARR multiple - priced for flawless execution
- Gross-margin exposure to LLM inference costs; economics undisclosed and potentially thinner than classic SaaS
- Concentration risk in a few flagship health-system accounts
- Undisclosed profitability - cash-burn dependent, reliant on continued private funding
Opportunities
- Revenue-cycle management / revenue-integrity automation — a $100B+ TAM far larger than documentation, where Ambience is now aiming
- Autonomous medical coding (its OpenAI-fine-tuned coding model claims better-than-physician accuracy) - a direct labor-replacement ROI story hospitals will pay for
- International and cross-specialty expansion; care-orchestration and patient-engagement modules
- Consolidation wave — could be an acquisition target for a payer/EHR/cloud strategic (Optum/UNH already an investor)
Threats
- Microsoft/Nuance (Dragon Copilot) bundling ambient AI into its EHR/Office distribution at scale
- Epic building native ambient documentation, commoditizing third-party scribes even as it partners with them
- Abridge's larger war chest (~$5.3B valuation in 2025, extended by a ~$316M Series E raise in Apr 2026) and share lead
- Pricing compression as ambient scribing becomes table-stakes; foundation-model providers moving up-stack
- Clinical liability / accuracy and reimbursement-fraud risk if auto-coding errs; regulatory scrutiny of AI in documentation
Moats, dependencies & bottlenecks
Moats
Once embedded in clinician workflow across specialties and wired into Epic, rip-and-replace is costly - but the moat is deployment depth, not proprietary tech.
OpenAI-RFT coding model and clinical fine-tunes are a real edge today, but sit atop third-party foundation models rivals can also access.
Cleveland Clinic exclusivity and academic-center co-development are hard for new entrants to replicate quickly.
Multi-module suite (scribe + CDI + coding + prior-auth) raises attach and retention vs. point tools; still early.
Dependencies
Technology / supplier Core inference and its fine-tuned coding model depend on OpenAI; also an investor (OpenAI Startup Fund). Pricing, availability, or up-stack competition are structural risks.
Distribution / integration Epic Toolbox/partner listing and Ambient Module/Haiku integration are key channels; Epic could build native ambient docs and disintermediate.
Hosting + inference compute; a variable-cost input tied directly to gross margin.
Customer / demand Revenue concentrated in a handful of large IDNs; long sales cycles and budget cycles gate growth.
Unprofitable, burn-funded; dependent on continued venture financing until self-sustaining.
Advantages
- Full-stack platform (documentation -> coding/CDI -> revenue integrity) vs. single-point scribes
- High claimed clinician utilization and academic-center validation
- Top-tier cap table and $243M of dry powder
- Early mover into autonomous medical coding with a purpose-built RFT model
- Epic partnership / Toolbox distribution
Weaknesses
- Third in share behind better-funded, better-distributed leaders
- Rich valuation vs. disclosed ARR (~40x)
- Undisclosed and inference-exposed margins
- Account concentration and dependence on external models + EHR channels
- Cash-burn / financing dependence
Bottlenecks
- Enterprise sales-cycle length and security/compliance review inside large health systems
- Foundation-model inference cost per encounter capping gross margin
- Clinical accuracy, safety, and reimbursement-compliance validation for autonomous coding
- Talent - clinical-AI and healthcare-domain ML engineers
- Integration engineering across heterogeneous EHR environments (Epic, Oracle Health, others)
Top signals & trends
Top signals
Bullish if attach rises · The key driver of the path to $100M+ ARR and of net retention.
Native Epic ambient docs would commoditize third-party scribes despite Toolbox listing.
An up-round validates the thesis; a flat/down round signals category margin doubts.
Bullish if validated · Hard-dollar ROI unlocks the larger RCM TAM.
Bearish if Ambience share stalls · Category is consolidating around the top players.
Trends
~$1B invested into the category in 2025; documentation burden and clinician shortage drive durable demand.
Foundation models make baseline note-generation cheap; value migrates to coding/RCM and workflow depth.
Toolbox/partnership distribution helps now, native builds threaten later.
Larger, ROI-clear TAM where Ambience is repositioning.
Raises the bar for accuracy and could favor validated enterprise vendors over lightweight tools.
Ecosystem & competitor graph
Suppliers feed the company; customers pull from it. Line thickness shows the strength of each tie (supply-chain dependency, customer earnings contribution). Hover to isolate a tie.
Private; foundation models + reinforcement fine-tuning for Ambience's coding model; also an investor.
Cloud/inference infrastructure (and, via Nuance, a competitor).
Cloud hosting/compute option for inference and data.
Upstream GPU compute underpinning model inference across the stack.
Alternative cloud + model provider in the healthcare-AI supply chain.
Private; exclusive contract, 300+ clinicians across 20 specialties - flagship reference.
Academic medical center enterprise account.
Large Texas health system account.
Health-system customer.
Specialty-group enterprise accounts.
Market-share leader (~33%) with EHR + Office distribution; DAX Copilot serves 600+ organizations - the incumbent to beat in ambient documentation.
Private; ~30% share, ~$5.3B valuation (2025) plus a ~$316M Series E extension (Apr 2026), heavily funded - the closest pure-play rival.
Private; AI clinical assistant (~10% share), dictation + ambient notes + coding suggestions.
EHR incumbent building its own clinical AI assistant; controls a large hospital install base.
Private; dominant EHR. Partners with Ambience via Toolbox but is building native ambient documentation - frenemy/platform risk.
Private; ~$19M ARR (Sacra, Mar 2025), ~26,000 clinicians (Apr 2026) - SMB/independent-clinician focused, less enterprise overlap.
Private; Augmedix (acquired by Commure) offers ambient documentation to health systems.
Public physician network offering a free/freemium scribe - commoditization pressure at the low end.